Wednesday, March 04, 2015 7:14:53 PM
-They currently have a $2 million lawsuit against them, and they have almost no revenue.
-They pay their CEO $500k a year, which is way too much IMO. I'd like to see them put some of that back in to R&D or in to other investments.
-They lease a small building for $65k a year, they could buy their own property for less than that if they were serious about their finances.
-and Bioheart has practically no assets.
- Also, like another member stated here, the Bioheart stock shares have lost >90% of its value since it became publicly traded.
I would be scared to invest in this stock for any length of time right now. If I had some information to let me know the company was turning its financial situation around, I may change my mind. I love the concept of the stem cell regeneration, it is the future of medicine.
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM